Furthermore, data from our group have demonstrated that uL3 autoregulates its own expression [33,34] and uL3 status is essential for cell response to certain anticancer drugs in p53 mutated lung and p53 deleted colon cancer cells. Here, RPL3 is linked to colonic neoplasm.